CRISPR patent

Weekend reads include herding brains, stem cells, & CRISPR

Stem-cells-the-niche-anti-aging

Every so often here on The Niche I list science and news articles worth a look as “weekend reads”. Below is my list for this weekend. Enjoy! The first article doesn’t really fit into the other main categories, but the title “herding brains” caught my eye. Stem Cells Stem cells and regenerative capacity in aging …

Weekend reads include herding brains, stem cells, & CRISPR Read More »

Why UC Berkeley deserves the main CRISPR patent

statment_gene_editing-tech

Some months back a USPTO court issued a ruling that most interpreted as meaning the Broad Institute had won the so-called ‘CRISPR patent battle’ in the U.S. and that UC Berkeley, Jennifer Doudna, and Emmanuelle Charpentier had lost. Now this week Berkeley has appealed that ruling. It seems the odds are against Berkeley prevailing in its appeal, but frankly …

Why UC Berkeley deserves the main CRISPR patent Read More »

CRISPR Update: Patents, Embryos, & IPOs, oh my

Joanne-Manaster-

It’s been a busy few weeks for the CRISPR arena so I’ve made a CRISPR Update. I’ve listed below links to some commentaries and key developments.   Fun Video interview on Read Science! with Joanne Manaster on my new book on CRISPR in humans, GMO Sapiens. CRISPR: Pursuit of profit poisons collaboration, Nature piece by Jacob Sherkow …

CRISPR Update: Patents, Embryos, & IPOs, oh my Read More »

Patent expert weighs in on CRISPR dispute between UC & Broad

CRISPR-patent-dispute

The patent dispute on CRISPR between UC/Jennifer Doudna and The Broad/Feng Zhang has been the subject of major attention including in a recent piece on Stanford Center for Law & Biosciences Blog. There is a lot of confusion over this important CRISPR dispute so I turned to a patent expert for their take on this via an interview …

Patent expert weighs in on CRISPR dispute between UC & Broad Read More »

New #CRISPR updates: Editas to go public, patent issues, dragons & more

CRISPR-dragon

A lot has been going on in the CRISPR world. Here are some key CRISPR updates. Editas has filed the paperwork on the road to going public as a company. Such an IPO, should it come to fruition, could raise billions of dollars. Will the other CRISPR companies like Caribou and CRISPR Therapeutics follow suit? Simplistically, …

New #CRISPR updates: Editas to go public, patent issues, dragons & more Read More »